Cargando…
Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292659/ https://www.ncbi.nlm.nih.gov/pubmed/37380558 http://dx.doi.org/10.1016/j.psyneuen.2023.106324 |
_version_ | 1785062864143253504 |
---|---|
author | Nuber-Champier, A. Cionca, A. Breville, G. Voruz, P. Jacot de Alcântara, I. Allali, G. Lalive, P.H. Benzakour, L. Lövblad, K.-O. Braillard, O. Nehme, M. Coen, M. Serratrice, J. Reny, J.-L. Pugin, J. Guessous, I. Landis, B.N. Griffa, A. Van De Ville, D. Assal, F. Péron, J.A. |
author_facet | Nuber-Champier, A. Cionca, A. Breville, G. Voruz, P. Jacot de Alcântara, I. Allali, G. Lalive, P.H. Benzakour, L. Lövblad, K.-O. Braillard, O. Nehme, M. Coen, M. Serratrice, J. Reny, J.-L. Pugin, J. Guessous, I. Landis, B.N. Griffa, A. Van De Ville, D. Assal, F. Péron, J.A. |
author_sort | Nuber-Champier, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10292659 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author(s). Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102926592023-06-27 Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] Nuber-Champier, A. Cionca, A. Breville, G. Voruz, P. Jacot de Alcântara, I. Allali, G. Lalive, P.H. Benzakour, L. Lövblad, K.-O. Braillard, O. Nehme, M. Coen, M. Serratrice, J. Reny, J.-L. Pugin, J. Guessous, I. Landis, B.N. Griffa, A. Van De Ville, D. Assal, F. Péron, J.A. Psychoneuroendocrinology Corrigendum The Author(s). Published by Elsevier Ltd. 2023-06-26 /pmc/articles/PMC10292659/ /pubmed/37380558 http://dx.doi.org/10.1016/j.psyneuen.2023.106324 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Corrigendum Nuber-Champier, A. Cionca, A. Breville, G. Voruz, P. Jacot de Alcântara, I. Allali, G. Lalive, P.H. Benzakour, L. Lövblad, K.-O. Braillard, O. Nehme, M. Coen, M. Serratrice, J. Reny, J.-L. Pugin, J. Guessous, I. Landis, B.N. Griffa, A. Van De Ville, D. Assal, F. Péron, J.A. Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title | Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title_full | Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title_fullStr | Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title_full_unstemmed | Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title_short | Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104] |
title_sort | corrigendum to “acute tnfα levels predict cognitive impairment 6–9 months after covid-19 infection” [psychoneuroendocrinology 153 (2023) 106104] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292659/ https://www.ncbi.nlm.nih.gov/pubmed/37380558 http://dx.doi.org/10.1016/j.psyneuen.2023.106324 |
work_keys_str_mv | AT nuberchampiera corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT cioncaa corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT brevilleg corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT voruzp corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT jacotdealcantarai corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT allalig corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT laliveph corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT benzakourl corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT lovbladko corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT braillardo corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT nehmem corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT coenm corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT serratricej corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT renyjl corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT puginj corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT guessousi corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT landisbn corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT griffaa corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT vandevilled corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT assalf corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 AT peronja corrigendumtoacutetnfalevelspredictcognitiveimpairment69monthsaftercovid19infectionpsychoneuroendocrinology1532023106104 |